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Structure of the Regulatory Hyaluronan
Binding Domain in the Inflammatory
Leukocyte Homing Receptor CD44
ing these processes, CD44, is an integral membrane
glycoprotein belonging to the Link module superfamily,
whose members include the matrix proteoglycans ag-
grecan, versican, and cartilage link protein (Day and
Prestwich, 2002). Expressed on a variety of different cell
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types, CD44 plays a pivotal role on leukocytes as aAnthony J. Day,1,* and David G. Jackson4,*
receptor for transendothelial migration at sites of inflam-1Medical Research Council Immunochemistry Unit and
mation (Lesley et al., 1997). In a fashion reminiscent of2 Laboratory of Molecular Biophysics
the integrins, CD44 is functionally inactive on resting3 Department of Biochemistry
T cells and monocytes, and binds HA only after T cellUniversity of Oxford
receptor triggering or after activation by proinflamma-South Parks Road
tory cytokines including TNF- and INF- (reviewed inOxford OX1 3QU
Pure and Cuff, 2001). In this way, discrete populations4 Medical Research Council Human Immunology Unit
of cells in peripheral blood are directed to transmigrateWeatherall Institute of Molecular Medicine
at inflammatory sites, where they recognize and respondJohn Radcliffe Hospital
to HA displayed on the surface of activated endothelialHeadington
cells (see Mohamadzadeh et al., 1998) as evidenced inOxford OX3 9DS
mouse models of arthritis (Mikecz et al., 1995), autoim-United Kingdom
mune diabetes (Weiss et al., 2000), and asthma (Katoh et5 Department of Anatomy
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Most HA binding proteins interact with ligand via aSummary
Link module (Day and Prestwich, 2002). The Link domain
is approximately 100 residues in length, comprising twoAdhesive interactions involving CD44, the cell surface
antiparallel  sheets and two  helices, stabilized by tworeceptor for hyaluronan, underlie fundamental pro-
highly conserved disulfide bridges, and is structurallycesses such as inflammatory leukocyte homing and
related to the C-type lectins (Blundell et al., 2003; Kohdatumor metastasis. Regulation of such events is critical
et al., 1996). In the Link module from TSG-6, which formsand appears to be effected by changes in CD44
an independently folded structure sufficient for high-N-glycosylation that switch the receptor “on” or “off”
affinity binding (Kahmann et al., 2000; Kohda et al.,under appropriate circumstances. How altered glyco-
1996), the HA-interaction surface is comprised of basicsylation influences binding of hyaluronan to the lectin-
and aromatic amino acids brought together from non-like Link module in CD44 is unclear, although evidence
contiguous regions, generally on loops between ele-suggests additional flanking sequences peculiar to
ments of secondary structure (Mahoney et al., 2001b).
CD44 may be involved. Here we show using X-ray
However, there is clear evidence that the HA binding
crystallography and NMR spectroscopy that these se-
domain of CD44 is more complex, involving the addi-
quences form a lobular extension to the Link module, tional contribution of sequences outside the consensus
creating an enlarged HA binding domain and a for- Link module just described. First, constructs comprising
merly unidentified protein fold. Moreover, the disposi- only the immediate Link module expressed in E. coli fail
tion of key N-glycosylation sites reveals how specific to refold and are functionally inactive (Banerji et al.,
sugar chains could alter both the affinity and avidity 1998); the CD44 primary sequence encodes an extra pair
of CD44 HA binding. Our results provide the necessary of cysteine residues, located in the N- and C-terminal
structural framework for understanding the diverse extensions, that is predicted to form a third disulfide
functions of CD44 and developing novel therapeutic linkage essential for stabilizing the HA binding domain.
strategies. Second, site-directed mutagenesis indicates that basic
amino acids in the flanking sequences participate in HA
Introduction binding (Peach et al., 1993), in addition to those located
in the Link module (Bajorath et al., 1998). Third, mapping
Cellular interactions with the extracellular matrix muco- of the epitopes for mAbs that block HA binding indicates
polysaccharide hyaluronan (HA) are fundamentally im- that the cluster of basic residues located in the C-ter-
portant for cell migration during tissue morphogenesis, minal extension is in close proximity to a region within
leukocyte trafficking, and tumor metastasis (Tammi et the first 22 amino acids of the mature protein (Liao et
al., 2002; Toole et al., 2002). The major receptor mediat- al., 1995). These and other observations have led to the
hypothesis that CD44 contains an extended HA binding
domain that is specially adapted for the regulation of*Correspondence: ajday@bioch.ox.ac.uk (A.J.D); djackson@hammer.
ligand binding (Jackson et al., 2001; Jackson, 2003).imm.ox.ac.uk (D.G.J.)
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to bind HA following cell activation involves differential charides showed that the minimum effective unit is a
6-mer, but that 8- to 12-mers are more efficient competi-glycosylation of the receptor, specifically, the remodel-
ing of N- and possibly O-linked carbohydrates (Lev- tors (Figure 1C). This confirms previous reports that the
minimum size of oligosaccharide required to displaceesque and Haynes, 1999). Although the precise structure
of the CD44 glycan chains and the details of their remod- high Mr HA from cell surface CD44 is between 6 and 10
saccharide units (i.e., HA6 or HA10), depending on theeling are not completely clear, some important features
are recognized. For example, studies with human my- cell background (see Lesley et al., 2000). Hence, the
bacterially expressed, nonglycosylated CD4420-178 mole-eloid cell lines and mouse lymphoid cell lines (Lesley et
al., 1995) have shown that HA binding can be triggered cule retains most or all of the functional characteristics
of native glycosylated CD44.by enzymatic removal of terminal sialic acid attached
to N-linked glycans on CD44 by treatment with N-glyca-
nase or by inhibition of biosynthesis with tunicamycin Determination of the CD44 HABD Structure by NMR
(Katoh et al., 1995). Moreover, the induction of HA bind- and X-Ray Crystallography
ing by TNF and phorbol ester, appears to be mediated To investigate the structure of the CD44 HABD and its
by activation of an endogenous sialidase (Gee et al., interaction with HA in solution, we applied the twin strat-
2003; Katoh et al., 1999; Kincade et al., 1997)—a likely egies of NMR spectroscopy and X-ray crystallography.
physiological regulator of CD44 function. Five con- The NMR structure of CD4420-178 was based on a total
served N-glycosylation sites (Asn25, Asn57, Asn100, of 2168 nuclear Overhauser effect (NOE)-derived inter-
Asn110, and Asn120) are present within the N-terminal proton distances (see Supplemental Figure S1 at http://
150 residues of CD44, and the individual mutation of www.molecule.org/cgi/content/full/13/4/483/DC1), 47
two of these, Asn25 and Asn120, has been shown to dihedral angle (φ) restraints, 56 H bonds between ele-
convert CD44 from an inducible to a constitutively active ments of secondary structure, and 157 13C and 146 13C
state in murine lymphoma cell lines (English et al., 1998). chemical shift values (see Table 1). The H bonds were
However, without knowledge of the 3D structure for determined from the observation of 37 slowly exchang-
CD44, it has not been possible to determine where these ing amide protons in regions of secondary structure
regulatory N-glycans lie in relation to the ligand binding and/or from NOE connectivities (see Supplemental Fig-
site or precisely how they might influence the interaction ure S2). In the final family of 20 structures (Figure 2A),
with HA. In this manuscript, we have elucidated the 3D residues 20–169 are generally well defined with an rmsd
structure of the HA binding domain of CD44 by X-ray for backbone atoms of 1.21A˚ from the mean structure.
crystallography and NMR spectroscopy and have Amino acids 170–178 (not shown) are significantly more
mapped the position of the HA-interaction surface. This disordered (see Table 1 and Figure 3A), and the high
has provided new insight into the mechanisms by which rmsd values observed in this region are consistent with
CD44 is regulated in vivo. the low number of NOEs identified per residue (Supple-
mental Figure S1). Furthermore, measurement of the
15N-{1H} NOE (Figure 3) revealed these amino acids toResults and Discussion
be dynamic in nature, consistent with their location in
the flexible membrane-proximal stalk region of CD44Expression and Characterization of the CD44
HA Binding Domain that is not directly involved in HA binding. NMR experi-
ments conducted on CD4420-178 samples with or withoutFor structural studies, we used soluble nonglycosylated
CD44 HA binding domains (HABD) expressed in E. coli 150 mM NaCl gave identical spectra, indicating that the
solution structure of the CD44 HABD determined herefrom the construct CD4420-178 (identical to that described
in Banerji et al. [1998] but without the N-terminal histi- is likely to be representative of that found under physio-
logical conditions.dine tag) which encompasses the Link module together
with its N- and C-terminal flanking sequences. We pre- The structure determined by X-ray crystallography
was generated from both nonderivatized and seleno-viously showed that the CD4420-178 HABD is very similar
to CD44Fc in terms of reactivity with the conformation- methione-derivatized (SeMet) CD4420-178 (see Experi-
mental Procedures). The 2-fold averaged SeMet singlesensitive mAbs BRIC-235 and F10.44.2, indicating that
the nonglycosylated protein expressed in E. coli shares wavelength anomalous dispersion (SAD) map was
readily interpretable for all but the last 9 amino acidsa common fold with the fully glycosylated CD44 ectodo-
main expressed in human 293T fibroblasts (Banerji et (Figure 2D), and the resulting structure of residues
Ala20-Tyr169 has been refined to an R factor of 18.4%al., 1999; data not shown).
Ligand binding assays revealed that CD4420-178 binds at 2.2 A˚ resolution (see Table 2). Therefore, the crystal
and solution structures of CD4420-178 (determined inde-biotinylated-HA (bHA) in a concentration-dependent
manner that is similar to that of CD44Fc (Figure 1A). The pendently) both show that residues 21–169 of human
CD44 (i.e., the N-terminal 149 amino acids of the matureobserved differences in the binding curves for the two
proteins may be attributed to avidity effects, since protein) constitute a structural domain.
The crystal and NMR structures of CD4420-178 are veryCD44Fc is a disulfide-linked dimer (Aruffo et al., 1990)
whereas CD4420-178 is monomeric. The plate binding similar (Figure 2), with close agreement over regions of
secondary structure. Superposition reveals an rmsd ofassay also confirmed the HA binding specificity of
CD4420-178 (Aruffo et al., 1990) inasmuch as no competi- 1.99 A˚ for 128 closely matching C atoms determined
using O. Such a global comparison provides a rathertion was observed even with high concentrations of ul-
trapure C4S and C6S (Figure 1B). poor index of their high degree of local similarity as can
be seen from comparisons of interresidual contacts inLast, competitive binding analyses with HA oligosac-
Structure of CD44 Hyaluronan Binding Domain
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Figure 1. Hyaluronan Binding Characteris-
tics of Nonglycosylated CD4420-178
(A) Comparison of biotinylated-HA (bHA)
binding to microtiter plates coated with either
glycosylated (CD44Fc) or nonglycosylated
CD4420-178.
(B and C) Competition of bHA binding by unla-
beled HA compared to the sulfated glyco-
saminoglycans C4S and C6S (B) or HA oligo-
saccharides of defined length (C). All values




In the tertiary structures described here, the Link mod-Table 1. NMR Restraints and Structural Statistics
ule of CD44 (residues 32–120) is very similar to that of
NOE restraints 2168
TSG-6 (Figure 4), being comprised of two  helices and
Intraresidue 949 two triple-stranded antiparallel  sheets, SI ( strands
Sequential 476 1, 2, and 6) and SII ( strands 3, 4, and 5), joined by H
Medium range (I  5) 190
bonds between 3 and 6; disulfide bridges connect 1Long range (I  5) 553
to 6 and the loop following 2 to the long loop betweenAverage number of NOE/residue 13.6
4 and 5 (Figure 2). However, in CD44, the regions
Dihedral angles (φ) 47 flanking the Link module provide an additional four 
Hydrogen bonds 56 strands (denoted 0, 7, 8, and 9) that extend the SI sheet.
Specifically, the N-terminal sequence (residues 20–31)Total number of restraints 2271
forms 0, a discontinuous strand interrupted by a 
Violationsa 0 bulge, which connects to 1 of the Link module (see
Distance restraints violated in single 0
Supplemental Figure S2). The C-terminal extensionstructure (0.3 A˚)
forms three  strands (7, 8, and 9), where 7 (residuesDistance restraints violated in all best 0
20 structures (0.1 A˚) 126–128) and 8 (residues 144–148) partner residues
Dihedral angle restraints (5	) 0 29–31 and 21–25 of 0, respectively, and 9 (153–159)
is connected to 8 (143–149). Thus, the two extensions,Precisionb
which are linked by a disulfide bridge between Cys28Backbone heavy atoms (A˚) 0.612
All heavy atoms (A˚) 1.129 and Cys129 (see Figure 4E), together form an additional
structural lobe in intimate contact with the Link moduleStructure quality by PROCHECKc
(Figure 4C). The large size of this lobe can be readilyResidues in most favored regions 57.0%
Residues in additional allowed regions 34.4% appreciated by comparisons of the surfaces presented
Residues in generously allowed regions 6.7% by the CD44 and TSG-6 structures (Figures 4B and 4C).
Residues in disallowed regions 1.9% Residues 21–169 that define the CD44 HABD are gen-
a Values are derived from the 20 lowest energy structures. erally well ordered. The 15N-{1H} NOE experiment and
b The average rmsd for the structure family was calculated by super- crystallographic B factors (Figure 3) reveal that some
imposing each of the 20 structures onto the coordinate set with the of the loop regions are highly dynamic. One of these
lowest target function. This superposition was over backbone Ca, (residues 90–95) is found on the long, hook-shaped seg-
C, N, and O atoms of residues 22–25, 28–30, 33–39, 46–56, 58–60,
ment between 4 and 5. In the crystal structure this62–72, 79–82, 85–88, 105–107, 115–120, 126–128, 143–149, 153–159.
loop contains two very short  strands that generate a3 Laskowski et al., 1996.
Greek-key architecture, with a half turn of helix between
them (see Figures 2 and 4). The flexibility of this region,
the crystal structure, with interresidual NOEs in the NMR with no-NOE/NOE ratios close to zero and high tempera-
structure (see Supplemental Data). The near complete ture factors (Figures 3A and 3B), is probably due to cis/
overlap of these values is testimony to the excellent trans isomerization of prolines 89 and 93. Other highly
agreement of the two techniques (see Supplemental dynamic residues are Asn110, a site for N-glycosylation
Figure S3). However, given the greater precision of a in the flexible 5-6 loop, and Glu126, the first residue
high-resolution crystal structure compared with that ob- of the 7 strand in the C-terminal extension (Figure 3B).
tained by NMR, especially with respect to details of side Flexibility of the latter residue probably derives from cis/
chain conformation, we have interpreted functional data trans isomerism of neighboring prolines 124 and 125.
below (including NMR shift mapping) on the basis of the Alignment of the CD44 amino acid sequence with that
X-ray structure. of the lymphatic hyaluronan receptor LYVE-1 reveals
that both proteins have additional conserved cysteines
Distinctive Features of the CD44 HABD in the N- and C-terminal regions flanking their Link mod-
A search of the protein database using DALI (Holm and ules (Figure 4A). This suggests the LYVE-1 HABD may
Sander, 1993) indicates that, while related to the Link also have an extended Link module structure. However,
module (and hence C-type lectins; Blundell et al., 2003),
the similarity with CD44 breaks down beyond strand 7
the structure of the CD44 HABD overall represents a
and LYVE-1 lacks the series of alternating hydrophobic
previously unrecognized fold, i.e., a novel elaboration
and hydrophilic amino acids (I144TITI148) that form 8.of the C-type lectin fold that is substantially larger than
Further structural studies will be required to resolvethe HABD of TSG-6. Inspection of the crystal and NMR-
these issues.derived structures for CD4420-178 reveals the HABD to
comprise two orthogonally disposed  helices and ten
Mapping the HA Binding Surface strands organized into a single long, curving  sheet
Previously, a study using site-directed mutagenesis(Figures 2C and 2D; Supplemental Figure S2). In the
identified four key residues within the CD44 Link modulerecently reported secondary structure for the CD44
(Arg41, Tyr42, Arg78, and Tyr79) as critical for the inter-HABD (Takeda et al., 2003) three of these  stands are
action with HA and a further five (Lys38, Lys68, Asn100,missing (e.g., 2, 5, and 7), and two unconnected 
Asn101, and Tyr105) as functionally important (Bajorathsheets (comprising two and five strands, respectively)
et al., 1998). Mapping of these amino acids onto thewere predicted. This incorrect secondary structure to-
CD44 HABD structure (Figure 5) reveals that all exceptpology and lack of any 3D structural information made
Lys68 (which is on the opposite face of the protein)correct analysis of their ligand binding experiments im-
possible. come together as a contiguous linear patch in a similar
Structure of CD44 Hyaluronan Binding Domain
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Figure 2. Structures of CD44 HABD Determined by NMR and Crystallography
Residues of strands in sheets I and II are colored gold and green, respectively, and helical residues magenta.
(A) Stereo C traces for the family of 20 structures determined in solution by NMR spectroscopy superimposed on the backbone heavy atoms
in the secondary structure elements.
(B) Representative electron density (shown in stereo) from the averaged SAD phased experimental map, contoured at 0.21 e
.A˚
3; the final
refined model is drawn in cylinder representation.
(C and D) Cartoon representations of the energy minimized averaged structure determined by NMR (C) and one molecule from the final
crystallographic structure (D); secondary structure was assigned on the basis of observed NOE contacts, protection of amide protons from
solvent exchange (C), and from the coordinates by the DSSP algorithm (D), respectively. Cysteine residues participating in disulfide bonds
are drawn in ball and stick representation.
Molecular Cell
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Figure 3. Flexibility and Conformational Change in Models of the CD44 HABD
(A) Quantitative measures of flexibility in the NMR and crystallographic models are plotted as a function of residue number. Parameters plotted
are (1) mean main chain temperature factor (thin continuous line), (2) no-NOE/NOE ratio for main chain amides (line with solid diamonds), (3)
the no-NOE/NOE ratio for assigned side chain amides (Asn/Gln residues; open squares), and (4) rms coordinate variance among the final
family of 20 structures calculated from NMR constraints (histogram).
(B) Cartoon representation of the CD44 fold (determined from crystallography), colored according to C temperature factor, with saturated
blue indicating B  10A˚2 and saturated red indicating B  40 A˚2.
(C and D) Slow exchanging amide protons (spheres) mapped onto ribbon representations of the solution structure, detectable after 2.75 (C)
and 18.5 (D) hr. Assigned protons detected in both free and HA6 bound CD4420-178 are depicted in gray green. Those observed in only the free
or only the bound protein are colored blue or red, respectively.
position to the HA binding surface in TSG-6. An earlier ing NMR. Initial 1H-15N-HSQC spectra acquired over a
range of HAn to protein stoichiometries (0:1 to 4:1) indi-study (Peach et al., 1993) also found that residues in
the N- and C-terminal extensions of CD44 (i.e., Arg29, cated that the protein/HA complex is in a slow exchange
regime on the NMR time scale for all the oligomers testedArg150, Arg154, Lys158, and Arg162) contribute to HA
binding. From Figure 5 it can be seen that Arg162 is (see Supplemental Figure S4 for HA6). Consequently, it
was necessary to assign the HABD de novo in its HA-close to Arg38 but that the others are at more distant
positions on this lobe of the HABD and do not form a bound form to unambiguously identify residues with per-
turbed resonances; HA6 was the shortest oligomer tocontinuous binding surface (e.g., Arg29, like Lys68, is
on the rear face of the domain). The widespread nature give essentially full perturbation of the protein. Spectra
acquired for CD4420-178 in the presence of HA6 (HA:CD44of these putative functional residues was unexpected
and is difficult to reconcile with a single HA binding ratio 4:1) allowed assignments of more than 72% of the
backbone NH, HN, and C nuclei in the complexed HABD.configuration within CD44.
Comparison of the chemical shifts for the free and
bound states of CD4420-178 (Supplemental Figure S5) indi-Detailed Analysis of the HA Binding Surface by NMR
To further characterize HA binding, we studied the inter- cates that a large number of nuclei are significantly per-
turbed upon interaction with HA6, using the thresholdaction between CD44 and HA oligomers (HA4–HA10) us-
Structure of CD44 Hyaluronan Binding Domain
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Table 2. Crystal and Data Collection
Space group P212121
Cell dimensions a  48.9 b  77.3 c  87.6       90
Resolution range (A˚) (overall, highest shell) 23.31–2.20, 2.32–2.20
Rsyma (overall, highest shell) 0.076, 0.181
I/(I) (overall, highest shell) 7.4, 3.1
Anomalous completeness(%) (overall, highest shell) 99.4, 98.2
Multiplicity (overall, highest shell) 3.8, 3.5
Wilson B factor (A˚2) 19.11
Phasing
Figure of meritb (after SOLVE, after RESOLVE) 0.30, 0.59
Refinement
Number of nonhydrogen protein atoms 2334
Number of water molecules 262
Rcryst (Rfree)c (23.31–2.20, 2.28–2.20) 0.18 (0.24), 0.19 (0.24)
Rms deviations from ideal bond lengths (A˚) 0.011
Rms deviation from ideal bond angles (	) 1.309
Structure quality according to PROCHECKd
Residues in core regions 224
Residues in additional allowed regions 37
Residues in generously allowed regions 1
Residues in disallowed regions 0
REFMAC maximum likelihood estimated rms coordinate error (A˚) 0.141
Rms B factor difference for covalently bonded atoms (A˚2) 0.657, 1.824
(main chain, side chain)









|Ih,j| where Ih,j is the intensity of the jth observation of unique reflection h.
b Mean figure of merit from SOLVE SAD phasing (first value) and after RESOLVE averaging/solvent flattening (value in parentheses).





|Foh|. All measured reflections were included in refinement except for the 5% disjoint set that was used for calculation
of the Rfree.
d Laskowski et al., 1996.
values ( for HN  0.2 ppm, NH  1.0 ppm, C  0.5 acid with an unassigned chemical shift change, is also
on this “back” face of the protein.ppm, and C  1.0 ppm) described previously for TSG-6/
HA interactions (Blundell et al., 2003). As seen in Figure In summary, the NMR analyses define a HA-interac-
tion surface on the Link module, centered on Arg41,5, amino acids that have significant chemical shift
changes for all of their HN, NH, and C nuclei are clustered Tyr42, Arg78, and Tyr79, and extended on either side
by Lys38, Asn100, and Asn101, with residues in thein three groups (colored yellow). Residues Lys38 and
Gly40–Ile44 make up a central patch, with two smaller C-terminal extension (e.g., Arg150, Arg154, and Arg162)
providing additional contacts (see below). However, thepatches on either side formed from Arg154–Tyr155, and
Asn164/Glu166; these segments of the protein experi- distribution of chemical shift changes indicates addi-
tional complexity in the binding event (i.e., a conforma-ence some of the largest HA-induced shift changes
(Supplemental Figure S5). Other amino acids that either tional rearrangement and/or multiple binding surfaces).
have perturbations of at least one HN, NH, or C nuclei
(red on Figure 5; including Arg78, Tyr79, and Arg150) or HA Binding Induces a Conformational Change in CD44
The widespread nature of the backbone shift perturba-are perturbed but unassigned (gray; e.g., Arg29 and
Arg162), extend these patches. Thus, the residues that tions is in marked contrast to the TSG-6 Link module,
where the HA-induced shift changes are all localizedare affected by HA binding are mostly confined to the
“front” face of the HABD structure, where they overlap around the ligand binding groove (Blundell et al., 2003),
one side of which is formed by the 4/5 loop in whichappreciably with the ligand binding residues predicted
from mutagenesis. a conformational rearrangement occurs (Kahmann et
al., 2000; Blundell et al., 2003).However, certain amino acids identified as functional
by mutagenesis do not experience significant backbone Therefore, the effect of HA binding on the CD4420-178
structure was investigated further by determining theshifts on HA6 binding. With the exception of Lys68, these
all lie adjacent to perturbed regions of the structure. For pattern of slow exchanging amide protons (sHN) in the
HABD/HA6 complex compared to the free protein.example, Asn100 and Asn101 are likely to be functional
since both have backbone shift perturbations close to Twenty-one common sHN were seen in free and bound
CD44 at the initial time point (2.75 hr; green in Figurecutoff levels, and residue 101 in mouse CD44 forms part
of the epitope for the HA blocking mAbs KM81 and 3C). Interestingly, twelve sHN were detected only in the
free CD44, and nine sHN were observed only in the com-KM114 (see Figure 6). Lys68 is on the opposite face of
the HABD (Figure 5D), in a region that has few chemical plex (colored blue and red, respectively), confirming that
HA binding causes a significant structural perturbation.shift perturbations approaching threshold levels (resi-
dues 60–72, Supplemental Figure S5), and is thus un- Six of the sHN protons observed only in free CD44 (resi-
dues 34, 37, 38, 118, 120, and 128) are involved in form-likely to interact with HA. In this regard, Arg29, an amino
Molecular Cell
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Figure 4. Comparison of the HA Binding Do-
mains from CD44, TSG-6, and LYVE-1
(A) Sequence alignment of the HABDs. Identi-
cal residues are shaded gray, and conserved
cysteines are indicated by dotted boxes. Sec-
ondary structural elements, determined from
solution or crystal structures, are shown
above the alignment. CD44 residues impli-
cated as “important” or “essential” for HA
binding are denoted with open or solid squares,
respectively. Sites for N-glycosylation are in-
dicated by open asterisks, which are filled in
cases where the glycosylation is believed to
modulate HA affinity.
(B and C) Semitransparent molecular surface
representations of the TSG-6 Link module
(Blundell et al., 2003) (B) and CD44 HABD (C)
in the same relative orientations; Link module
surfaces are colored gray, and CD44 HABD
extensions colored gold. Side chain positions
for HA binding residues in CD44 (essential,
red; important, light blue [Link module], green
[present in extensions]) are compared with
those in the TSG-6 Link module (red; see Ma-
honey et al., 2001b).
(D and E) Cartoon representation of the
TSG-6 Link module (D) and CD44 HABD (E)
folds in the same orientations as for (B) and
(C), respectively; Link modules are colored
white, CD44 HABD extensions colored gold,
and disulfide bonds colored red (ball and
stick representation).
ing H bonds across  strands (0:1, 1:6, and 0:7; involved in interresidual H bonds interactions in the crys-
tal structure (Supplemental Figure S6), indicating thatsee Supplemental Figure S2). Clearly these bonds are
destabilized on interaction with HA. As shown in Figure this is representative of the CD44 HABD in its un-
bound state.3C, most of the sHN protons seen only in free CD44
(blue) are clustered close to the interface between the The nine sHN observed solely in the HABD/HA6 com-
plex are mostly in loop regions that may become moreLink module and the N- and C-terminal extensions, lying
on a central axis. This suggests that the interaction of structured and less dynamic on HA binding (red on Fig-
ure 3C); only the amide proton of Leu107 is involved inHA with CD44 induces a change in relative orientation
of these subdomains, with a corresponding alteration an interstrand H bond (see Supplemental Figure S2).
The finding that almost twice as many sHN are detectedin the H bond network (see Supplemental Data at http://
www.molecule.org/cgi/content/full/13/4/483/DC1 for for the HA6 bound protein compared to free CD44 after
18.5 hr indicates a ligand-induced stabilization of thefurther details). It should be noted that all but one of
the sHN assigned in the free protein were found to be HABD structure (see Figure 3D). The eleven long-lived
Structure of CD44 Hyaluronan Binding Domain
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Figure 5. Mapping the CD44 HA Binding Surface
The HABD (X-ray structure) is shown as ribbon (A and C) or contact surface (B and D) representations; structures in (A) and (B) are rotated
180	 around the vertical axis relative to (C) and (D). Nuclei (A and C), shown as spheres, or their related amino acids (B and D) are colored
according to degree of chemical shift perturbations on binding HA6. Yellow denotes residues with HN, NH, and C nuclei that all exhibit a
significant perturbation (see text). Red indicates amino acids that have at least one affected HN, NH, or C nucleus. Residues with perturbed
carbonyl (C) resonances are colored dark pink; 93% and 71% of the assignable backbone C were derived for the free and bound protein,
respectively. C nuclei of residues where HN, NH, and C were unassigned in the complex are shown in gray (see Supplemental Figure S5).
Positions of residues implicated in HA binding on the basis of site-directed mutagenesis are shown in (B) and (D) for comparison.
sHN observed only in the complex (red) are all found Determining the Size of HA Accommodated
in the Binding Sitewithin the Link module, being mostly located on the 2
helix, 3, and 4 strands. Overall, these data suggest Comparison of 1H-15N-HSQC experiments on CD4420-178
in the presence of HA4, HA6, HA8, or HA10 revealed thatthat the interaction of HA with CD44 stabilizes the Link
module portion of the HABD while inducing a change these oligomers all give rise to very similar shift perturba-
tions (see Supplemental Figure S7). This indicates thatin its orientation relative to the rest of the structure.
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Figure 6. Hypothetical Models for HA Binding to the CD44 HABD
(A–D) HA octasaccharides are shown in two different orientations (i.e., mode 1 [A and C] or mode 2 [B and D]) on a molecular surface
representation of CD44. In (A) and (B) the surface is colored according to electrostatic potential (GRASP program), with red and blue
corresponding to potentials 
2 kT/e and 2 kT/e, respectively; the map is contoured at a level of 
2 kT/e. In (C) and (D), residues implicated
in HA binding are color-coded as in Figure 4. Likely contact residues for each binding mode are appropriately annotated. Yellow spheres
visible through the semitransparent surface denote positions of nuclei that show significantly perturbed chemical shifts upon binding to HA6,
but not with HA4. In (E) and (F) positions of N-linked glycosylation sites (magenta) and epitopes of monoclonal antibodies (activating, blue;
blocking, green) are shown on the front (E) and back (F) faces of the HABD; (E) is in the same orientation as (A)–(D). On (F) the locations of
residues Arg29 and K68, the mutation of which reduces HA binding, are also indicated; note that the view of Asn120 is largely occluded at
this viewing angle by the loop between  strands 6 and 7.
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they bind at essentially the same site on CD44 and all cleavage by neuraminidase led to activation of HA bind-
cause a similar ligand-induced conformational change. ing (English et al., 1998).
However, there are several distinct differences between Although it is readily apparent from our studies how
the effects of HA4 and the longer oligomers (see Supple- a negatively charged sugar chain attached to Asn25
mental Data), and a single clear (but unassigned) differ- could directly obstruct HA binding (see Figure 6), this
ence in the CD4420-178 HSQC spectra in the presence of is less obvious for Asn120, which is on the rear face of
HA6 and HA8. This suggests that an 8-mer is likely to be the HABD, close to Arg29 (Figure 6F). A likely explanation
the minimum size of HA that completely occupies the is that charged glycans attached at Asn120 interfere
HA binding site in the nonglycosylated CD44 HABD used with CD44 self-association, a process believed to have
here, consistent with the results of the ELISA experi- physiological importance in regulating HA binding avid-
ments described above. ity (see Lesley et al., 2000). Such clustering can also be
induced by “superagonist” mAbs such as IRAWB14 and
Does CD44 Have Two Different Modes of HA Binding? IRAWB26 that trigger large increases (50- to 100-fold)
The residues within CD44 strongly implicated in HA in HA binding (Lesley et al., 1993; Zheng et al., 1995),
binding (Lys38, Arg41, Tyr42, Arg78, Tyr79, Asn100, possibly by orientating the crosslinked CD44 molecules
Asn101, Arg150, Arg154, Arg162; based on mutagenesis for optimal binding to adjacent sites along the same HA
and NMR shift data) map onto a single face of the HABD; molecule (Lesley et al., 2000). Interestingly, our studies
this region is surrounded on all sides by a shell of nega- reveal that the shared binding site for IRAWB14 and
tive electrostatic charge that may help to guide the poly- IRAWB26 (D64QMKLALS71 in mouse CD44, correspond-
anionic HA toward its docking site via charge repulsion ing to A64QMEKALS71 in the human [Zheng et al., 1995])
(Figure 6 and Supplemental Figure S8). However, these lies immediately adjacent to Asn120 in the CD44 struc-
residues are too widespread to be able to interact with ture and is centered on Lys68, one of only two residues
a single octasaccharide. As shown in Figure 6, this could on the rear face of the HABD whose mutation influences
be explained if CD44 was able to accommodate HA HA binding (Bajorath et al., 1998).
molecules in two different binding positions or modes. These data are therefore consistent with the notion
In the first mode, HA8 would thread from Asn100/Asn101 that the rear face of CD44 may be involved in regulating
at one end toward Arg150/Arg154 at the other (Figures HA binding, either by enhancing the tandem juxtapo-
6A and 6C). This arrangement is consistent with the sition of monomer HABDs in a fashion analogous to
different backbone amide perturbations observed for IRAWB14/IRAWB26 crosslinking or by effecting a con-
Thr27, Cys28, and Lys38 (yellow on Figure 6C) in the formational change leading to high-affinity binding. Spe-
presence of HA4 and HA6 (see Supplemental Data) and cifically, the presence of terminal sialic acid residues
with the fact that Arg 154 forms part of the epitope for
on Asn120 could prevent formation of CD44 dimers or
the HA-blocking mAb 5F12 (Liao et al., 1995). Interest-
higher oligomers through charge repulsion. While confir-
ingly, the HA in mode 1 is also in a similar orientation
mation of such a role for Asn120-linked glycans mustto an octasaccharide modeled onto the bound confor-
await experimental validation, it is worth noting thatmation of the TSG-6 Link module (Blundell et al., 2003).
sialylated O-glycans have been proposed to regulateFurthermore, recently reported cross-saturation experi-
receptor self-association in the case of the T cell core-ments (Takeda et al., 2003), when reinterpreted on the
ceptor CD8 and the leukocyte receptor tyrosine phos-basis of our 3D structure, are consistent with this mode
phatase CD45 (Moody et al., 2001; Xu and Weiss, 2002).of interaction (it should be noted that neither Arg41 nor
Such a role for N-glycan chains, as exemplified by CD44,Tyr42 were identified as HA binding residues in the
is to our knowledge unique.Takeda study).
In conclusion, the enlarged CD44 HABD allows forIn the alternative mode 2, the HA molecule would
regulation of ligand binding in response to proinflamma-make bonded interactions with Lys38 or Arg162 and lie
tory cytokines and other extracellular factors that trans-more completely in the uncharged region of the interac-
duce changes in receptor N-glycosylation. The se-tion surface. Since modes 1 and 2 overlap (Figures 6C
quences flanking the Link module, which are unique toand 6D), it would not be possible for them to be used
CD44, play a pivotal role by providing the attachmentsimultaneously in an individual CD44 molecule. It is pos-
sites for key N-glycans (Asn25 and Asn120) whose ap-sible that changes in glycosylation in vivo (e.g., at Asn25)
propriate modification may either directly block HA bind-could determine which mode of interaction is utilized
ing or reduce receptor avidity by preventing criticalby CD44.
homooligomerization. This regulation of binding is fun-
damental to many of the biological roles in which CD44Regulation of CD44 Function by N-Glycosylation
participates, such as transendothelial migration of leu-It is well established in vitro that inhibition of N-glycan
kocytes from the circulation to the sites of inflammationbiosynthesis or enzymatic hydrolysis of N-linked gly-
and the invasion of end organ tissue by metastatic tumorcans or their terminal sialic acid residues can “activate”
cells (Bartolazzi et al., 1994; De Grendele et al., 1997;CD44 in certain cell types (Katoh et al., 1995, 1999;
Mikecz et al., 1995; Katoh et al., 2003). The structureLesley et al., 1995). Of the five N-glycosylation sites
presented in this paper provides a platform for furtherwithin the CD44 HABD, two in particular, Asn25 and
studies leading to the rational design of small moleculeAsn120, have been identified as important on the basis
inhibitors of HA binding and CD44 self-association asthat their individual mutation to serine leads to binding
potential therapeutic agents for the treatment of inflam-activation (English et al., 1998). Moreover, both were
shown to carry terminal 2,3 linked sialic acid whose matory and malignant diseases.
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Experimental Procedures ment were performed. At round eight, the program PROCHECK
(Laskowski et al., 1996) was used to check the model. This revealed
no residues in disallowed regions of the Ramachandran plot, andReagents
The monoclonal antibodies BRIC-235 and F10.44.2 were obtained 3 of the 304 visible residues in generously allowed regions. Of these,
two residues (residues 107 and 112 of chain A) were in weak electronfrom Professor D. Anstee (Bristol, UK) and SouthernBiotech (Bir-
mingham, AL) respectively. Selenomethionine was purchased from density, and their conformations were reset so as to better agree
with the database of known structures. The last, residue 126, wasCalbiochem (Nottingham, UK). 15N ammonium chloride (99.9 atom
%) and D-glucose-13C6 (99.2 atom %) were supplied by CK Gas clearly defined in electron density and presumably lies in a region
of slight local strain. In the last two rounds of refinement, the tightProducts (Cambridge, UK). Soluble glycosylated CD44Fc was pro-
duced as described in Banerji et al. (1998). HA oligosaccharides of NCS restraints were released. This decreased Rcryst by 0.03 and Rfree
by 0.01. Data collection and refinement statistics are shown in Tabledefined length (HA4, HA6, HA8, HA10, HA12, and HA20-24) were prepared
either as described in Lesley et al. (2000) or Mahoney et al. (2001a). 2. The structure appears under Protein Data Bank accession
code 1UUH.
Cloning and Expression of the Soluble CD44
HA Binding Domain NMR Spectroscopy
NMR samples were prepared from lyophilized CD4420-178 in 10% (v/v)The ectodomain construct CD4420-178 comprising the final residue
from the signal sequence and the first 158 residues from the N or 100% (v/v) D2O (containing 0.02% [w/v] Na-azide) and adjusted
to pH 6.5. All NMR experiments were recorded at 25	C at protonterminus of the mature human protein was prepared by PCR amplifi-
cation from a full-length cDNA clone using the forward primer CCAT frequencies of 500, 600, or 750 MHz. Multidimensional data sets
were recorded in a phase-sensitive manner with quadrature detec-GGccatgg56CGCAGATCGATTTGAATATA containing an NcoI site
(lowercase) and the reverse primer TGGAagatctTCAC530A CGTCAT tion by the States/TPPI method (States et al., 1982). The 1H carrier
frequency was set to the water resonance (4.75 ppm) and broadbandCATCAGTAGGG containing a BglII site for ligation into the expres-
sion vector pET19b. Protein was expressed and purified to homoge- decoupling of the heteronuclei was achieved using GARP or WALTZ-
16 sequences at field strengths of 833 Hz (15N) and 2500 Hz (13C)neity as described previously (Banerji et al., 1998). For heavy metal
replacement the construct was transformed into E. coli B834 DE3 (Shaka et al., 1985).
Assignment (backbone and side chain) was based on HNCA,and grown at 30	C in M9 minimal media supplemented with Mg2SO4
( mM), FeSO4 (25g/ml), glucose (0.4% [w/v]), amino acids (40g/ml CBCA(CO)NH, CC(CO)NH, 1H-15N-TOCSY-HSQC (mixing time 25
ms), 1H-15N-NOESY-HSQC (mixing times 70 or 150 ms), and HCCH-each, with seleno-L-methionine substituted for L-methionine) and
vitamins (riboflavin, niacinamide, pyridoxine monohydrochloride, TOCSY (mixing time 11 ms) spectra recorded on 1 mM protein
samples at 600 or 750 MHz. The 3JHN-H coupling constants werethiamine [1 g/ml each]). For single (15N-) and double (13C,15N-) label-
ing, bacteria were grown at 30	C in enriched M9 media (0.6% [w/v] determined using line width analysis of 2D-NOESY and 1H-15N-
HMQC-J experiments. NOE correlations were derived fromanhydrous Na2HPO4, 0.3% [w/v] KH2PO4, 0.05% [w/v] NaCl, 0.085%
[w/v] yeast nitrogen base, 0.1 mM CaCl2, 1 mM MgSO4) supple- 15N-edited and 2D-D2O-NOESY experiments (mixing times of 70 ms).
Amide exchange with solvent was observed with 15N-1H-HSQC ex-mented with 15N H4Cl (0.052% [w/v]) and 13C6 glucose (0.15% [w/v]),
as appropriate. periments recorded on a 0.3 mM sample (500 MHz) at 105 min
intervals (following an initial delay of 60 min) after the addition of 5The molecular masses of CD4420-178 and seleno-CD4420-178 as-
sessed by electrospray ionization mass spectrometry were 17579.5 mM MES (pH 6.5) in 100% D2O to lyophilized protein; this was also
performed in the presence of 1.2 mM HA6. The 15N-{1H} NOE wereand 17673.5 Da, respectively, consistent with the expected sizes of
the polypeptides after cleavage of the N-terminal methionine (e.g., measured at 500 MHz by comparison of spectra recorded either with
(NOE) or without (no-NOE) 1H saturation, as described in Pickford et17,580.4 Da for unmodified protein). Mass spectrometry indicated
that there was 100% and 98% incorporation of 15N and 13C iso- al. (2001). Data were processed using FELIX 2.3 (Biosym Inc.), and
referenced and analyzed with XEasy as described in Kahmann ettopes, respectively.
al. (2000). Peak heights in the 15N-{1H} NOE experiment were mea-
sured with the program SPARKY (Goddard and Knelle, 2003). NOECrystallization of CD4420-178, Data Collection, and Analysis
intensities for each data set were measured and calibrated usingCD4420-178 was crystallized by hanging-drop vapor diffusion. Droplets
interproton distances in regions of regular secondary structure, andof 1 l protein sample 1 l well solution were suspended above
converted into four distance restraint categories with upper limitswell solutions of 12% PEG 3350, 50 mM NaCl, and 10% glycerol.
of 2.7 A˚, 3.5 A˚, 5.0 A˚, and 6.2 A˚. These restraints were used withinCrystals grew to 5 5  300 m3 over 1 week. The same conditions
the program CNS v1.1 (2001; see Brunger et al., 1998) in an ab initiowere used for crystallization of the selenomethionine protein except
simulated annealing protocol which utilizes the SOPHIE algorithmthat monothioglycerol (100 g/ml final concentration) was added to
(Pickford et al., 2001), with 13C and 13C chemical shift values usedboth the protein and well solutions.
to provide additional structural information (see Wishart and Sykes,SAD data were collected from the SeMet CD4420-178 crystal to 2.2 A˚
1994). Hydrogen bond restraints were included as described in Pick-at beamline ID14.4 of the ESRF, using 0.9795 A˚ wavelength radiation.
ford et al. (2001). A total of 500 structures were calculated, and theA data set from CD4420-178 crystal was also collected at Elettra at
30 of lowest target function refined by three further cycles of the1.5 A˚ wavelength to enhance the anomalous signal of sulfur (absorp-
cooling step from the ab initio calculation, followed by extensivetion edge at 2475 eV [Weiss et al., 2001]). For this data set, a helium
restrained energy minimization (see Pickford et al., 2001). The 20path was employed. SOLVE was able to determine positions of
lowest energy structures were used to calculate a mean structureselenium atoms in the ESRF data set and to produce electron density
using CNS (Protein Data Bank accession code 1POZ).of reasonable, but not readily interpretable, quality. Determination
1H-15N-HSQC experiments were performed on 0.3 mM 15N-labeledof the positions of the sulfurs in CD4420-178 was accomplished by
CD4420-178 in the presence of HA4, HA6, HA8, or HA10 at sugar to proteincrossphasing an anomalous difference Fourier of the Elettra dataset.
stoichiometries of 0:1, 0.5:1, 1:1, 2:1, and 4:1. HNCA, HN(CO)CA,These sites defined the noncrystallographic symmetry (NCS) trans-
and HNNH (as in Panchal et al., 2001), but modified to be a 2Dformation relating the two monomers in the asymmetric unit, permit-
experiment (S.A. Colebrooke, G. Verdone, and I.D.C., unpublishedting structure determination by the programs SOLVE/RESOLVE (Ter-
data); spectra were acquired for 1 mM CD4420-178 samples containingwilliger and Berendzen, 1999), O (Jones et al., 1991), and programs
HA6 at a 4-fold molar ratio. Spectra from free and bound proteinof the CCP4 suite (CCP4, 1994). The initial maps, into which RE-
were used to determine 1HN 15NH and 13C assignments for the com-SOLVE was able to automatically build a 70% complete structure,
plex. HNCO spectra were recorded on both free and HA6-containingwere calculated at 2.6 A˚ resolution. This model could readily be
samples for measurement of 13C.completed in the first round of interactive model building in O, and
was refined with tight NCS restraints in the program REFMAC using
all data to 2.2 A˚ resolution. Water positions were determined manu- HA Binding Assays
For the standard assay, 96-well microtiter plates (Nunc Maxisorp)ally by inspection of the chemical environment of high (3) peaks
in difference Fouriers. Ten rounds of REFMAC and interactive refine- were coated (100 l/well, 6 hr, 20	C) with samples of CD4420-178 or
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CD44Fc (5–40 g/ml) in 15 mM sodium carbonate buffer (pH 9.3) De Grendele, H.C., Estess, P., and Siegelman, M.H. (1997). Require-
ment for CD44 in activated T cell extravasation into an inflammatoryfollowed by washing in PBS and blockage of unreacted sites in PBS
containing 1% (w/v) BSA, 0.05% (w/v) Tween 20. Plates were then site. Science 278, 672–675.
incubated with biotinylated HA (5 g/ml, 20	C, 1 hr), prepared as English, N.M., Lesley, J.F., and Hyman, R. (1998). Site-specific de-
described previously (Mahoney et al., 2001b), and bound HA de- N-glycosylation of CD44 can activate hyaluronan binding, and CD44
tected with horseradish peroxidase-conjugated streptavidin (Dako) activation states show distinct threshold densities for hyaluronan
and O-phenylenediamine on a Bio-Rad microplate reader at OD490nm. binding. Cancer Res. 58, 3736–3742.
The relative affinity of CD44 for other GAGs was determined in a
Gee, K., Kozlowski, M., and Kumar, A. (2003). TNF induces function-modification of the standard assay in which CD4420-178 was coated
ally active hyaluronan-adhesive CD44 by activating silidase throughat 20 g/ml, and competing GAGs (C4S and C6S; Seikagaku Corpo-
p38 mitogen-activated protein kinase in lipopolysaccharide-stimu-ration) were added to the plates (10 to 1000 g/ml) 15 min prior to
lated human monocytic cells. J. Biol. Chem. 278, 37275–37287.the addition of biotinylated HA. A similar modification was used
Goddard, T.D., and Kneller, D.G. (2003). SPARKY (University of Cali-to assess competition with defined HA oligosaccharides (HA4 to
fornia, San Francisco), www.cgl.ucsf.edu/home/sparky/.HA22-24).
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